Hologic stock holds $76 after delisting flag and earnings data

Hologic stock (US4364401012) traded at $76.00 on August 20, 2026, with a $16.97 billion market cap and a 52-week range of $51.90 to $76.07.

The latest market screen also flags a Hold rating, 12 analysts in coverage and expected earnings growth of 7.94% to $4.62 per share, versus $4.28 previously.

Market setup

That mix leaves the shares very close to the top of their 52-week band, with the quote sitting just 7 cents below the high.

A separate market note marks the company as potentially delisted, which is the kind of status risk that can matter more than the daily price move for investors tracking the name.

Latest fundamentals

The most recent quarter in the market overview shows earnings per share of $1.04, which missed the $1.09 consensus by 5 cents, while quarterly revenue rose 2.5% year over year.

That comparison matters because it shows a stock that is still priced on forward expectations rather than a clean earnings beat, even as the next-year EPS estimate points to $4.62.

What the screen says

The same overview puts the trailing net income at $565.70 million and net margin at 13.18%, giving investors a snapshot of profitability behind the share price.

For Hologic, the market now looks more focused on valuation, coverage and listing status than on a fresh operating catalyst.

Product line

The company's diagnostics and breast health portfolio remains the core commercial engine, with testing systems and imaging products carrying the brand in hospitals and clinics.

Closing view

Hologic stock was last quoted at $76.00 on August 20, 2026, leaving the shares near their 52-week high of $76.07.

Company details

Company: Hologic, Inc.
ISIN: US4364401012
Ticker: HOLX
Exchange: NASDAQ
Price (as of August 20, 2026, 4:00 p.m. ET): $76.00 USD
Market cap: $16.97 billion (as of August 20, 2026)
Sector / Industry: Healthcare / Healthcare Equipment & Supplies
Index membership: Nasdaq-100